Yuan L, Meng Y, Xiang J
Sci Rep. 2024; 14(1):13093.
PMID: 38849490
PMC: 11161632.
DOI: 10.1038/s41598-024-64015-6.
Chen Q, Sun M, Han X, Xu H, Liu Y
J Biomed Res. 2023; 37(6):492-506.
PMID: 37964759
PMC: 10687533.
DOI: 10.7555/JBR.37.20230112.
Lopez-Robles C, Scaramuzza S, Astorga-Simon E, Ishida M, Williamson C, Banos-Mateos S
Nat Struct Mol Biol. 2023; 30(7):958-969.
PMID: 37322239
PMC: 10352136.
DOI: 10.1038/s41594-023-01014-7.
Hu B, Yin G, Sun X
Sci Rep. 2022; 12(1):10231.
PMID: 35715463
PMC: 9205943.
DOI: 10.1038/s41598-022-14266-y.
Cicek E, Circir A, Oyken M, Caliskan O, Dioken D, Guntekin Ergun S
Oncogene. 2021; 41(2):220-232.
PMID: 34718348
PMC: 8883427.
DOI: 10.1038/s41388-021-02086-9.
Phosphoinositide Recognition Sites Are Blocked by Metabolite Attachment.
Kervin T, Wiseman B, Overduin M
Front Cell Dev Biol. 2021; 9:690461.
PMID: 34368138
PMC: 8340361.
DOI: 10.3389/fcell.2021.690461.
Regulatory role of sorting nexin 5 in protein stability and vesicular targeting of vesicular acetylcholine transporter to synaptic vesicle-like vesicles in PC12 cells.
Sun M, Han X, Chang F, Xu H, Colgan L, Liu Y
J Biomed Res. 2021; 35(5):339-350.
PMID: 34230437
PMC: 8502691.
DOI: 10.7555/JBR.34.20200095.
Regulation of the Phosphoinositide Code by Phosphorylation of Membrane Readers.
Kervin T, Overduin M
Cells. 2021; 10(5).
PMID: 34069055
PMC: 8156045.
DOI: 10.3390/cells10051205.
Identification of prognostic and bone metastasis-related alternative splicing signatures in mesothelioma.
Huang R, Zheng Z, Liu S, Yan P, Song D, Yin H
Cancer Med. 2021; 10(13):4478-4492.
PMID: 34041868
PMC: 8267146.
DOI: 10.1002/cam4.3977.
Inhibitory role of peroxiredoxin 2 in LRRK2 kinase activity induced cellular pathogenesis.
Yan K, Zhang W, Han X, Chang F, Liu Y
J Biomed Res. 2020; 34(2):103-113.
PMID: 32305964
PMC: 7183297.
DOI: 10.7555/JBR.33.20190090.
SNX16 activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of eEF1A2 in colorectal cancer development.
Shen Z, Li Y, Fang Y, Lin M, Feng X, Li Z
Mol Oncol. 2019; 14(2):387-406.
PMID: 31876369
PMC: 6998659.
DOI: 10.1002/1878-0261.12626.
Loss of renal SNX5 results in impaired IDE activity and insulin resistance in mice.
Li F, Yang J, Villar V, Asico L, Ma X, Armando I
Diabetologia. 2017; 61(3):727-737.
PMID: 29080975
PMC: 6342204.
DOI: 10.1007/s00125-017-4482-1.
Sorting nexin 5 and dopamine d1 receptor regulate the expression of the insulin receptor in human renal proximal tubule cells.
Li F, Yang J, Jones J, Villar V, Yu P, Armando I
Endocrinology. 2015; 156(6):2211-21.
PMID: 25825816
PMC: 4430625.
DOI: 10.1210/en.2014-1638.
Endosomal type Iγ PIP 5-kinase controls EGF receptor lysosomal sorting.
Sun Y, Hedman A, Tan X, Schill N, Anderson R
Dev Cell. 2013; 25(2):144-55.
PMID: 23602387
PMC: 3740164.
DOI: 10.1016/j.devcel.2013.03.010.
Disruption of sorting nexin 5 causes respiratory failure associated with undifferentiated alveolar epithelial type I cells in mice.
Im S, Jeong H, Jeong H, Kim K, Hwang D, Ikegami M
PLoS One. 2013; 8(3):e58511.
PMID: 23526992
PMC: 3602295.
DOI: 10.1371/journal.pone.0058511.
SNX5 is essential for efficient macropinocytosis and antigen processing in primary macrophages.
Lim J, Teasdale R, Gleeson P
Biol Open. 2012; 1(9):904-14.
PMID: 23213485
PMC: 3507233.
DOI: 10.1242/bio.20122204.
The F-BAR protein PACSIN2 regulates epidermal growth factor receptor internalization.
de Kreuk B, Anthony E, Geerts D, Hordijk P
J Biol Chem. 2012; 287(52):43438-53.
PMID: 23129763
PMC: 3527931.
DOI: 10.1074/jbc.M112.391078.
Quantitative proteomic profiling identifies protein correlates to EGFR kinase inhibition.
Kani K, Faca V, Hughes L, Zhang W, Fang Q, Shahbaba B
Mol Cancer Ther. 2012; 11(5):1071-81.
PMID: 22411897
PMC: 3959865.
DOI: 10.1158/1535-7163.MCT-11-0852.
The SNX-PX-BAR family in macropinocytosis: the regulation of macropinosome formation by SNX-PX-BAR proteins.
Wang J, Kerr M, Karunaratne S, Jeanes A, Yap A, Teasdale R
PLoS One. 2010; 5(10):e13763.
PMID: 21048941
PMC: 2966440.
DOI: 10.1371/journal.pone.0013763.
Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury.
Liu H, Li W, Ahmad M, Miller T, Rose M, Poloyac S
Neurobiol Dis. 2010; 41(2):318-28.
PMID: 20933087
PMC: 3014436.
DOI: 10.1016/j.nbd.2010.09.020.